Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Depreciation and Depletion: 2016-2025

Historic Depreciation and Depletion for Wave Life Sciences (WVE) over the last 10 years, with Sep 2025 value amounting to $856,000.

  • Wave Life Sciences' Depreciation and Depletion fell 9.70% to $856,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 13.83%. This contributed to the annual value of $3.9 million for FY2024, which is 22.00% down from last year.
  • According to the latest figures from Q3 2025, Wave Life Sciences' Depreciation and Depletion is $856,000, which was down 1.04% from $865,000 recorded in Q2 2025.
  • In the past 5 years, Wave Life Sciences' Depreciation and Depletion ranged from a high of $1.9 million in Q1 2021 and a low of $856,000 during Q3 2025.
  • For the 3-year period, Wave Life Sciences' Depreciation and Depletion averaged around $1.0 million, with its median value being $999,000 (2024).
  • Data for Wave Life Sciences' Depreciation and Depletion shows a maximum YoY dropped of 29.71% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Wave Life Sciences' Depreciation and Depletion stood at $1.8 million in 2021, then fell by 14.37% to $1.5 million in 2022, then decreased by 29.71% to $1.1 million in 2023, then declined by 15.73% to $911,000 in 2024, then fell by 9.70% to $856,000 in 2025.
  • Its last three reported values are $856,000 in Q3 2025, $865,000 for Q2 2025, and $875,000 during Q1 2025.